1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in the United States

Biotechnology in the United States

  • January 2016
  • -
  • MarketLine
  • -
  • 37 pages

Introduction

Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United States biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The US biotechnology market is expected to generate total revenues of $147.0bn in 2015, representing a compound annual growth rate (CAGR) of 12% between 2011 and 2015.

- The medical/healthcare segment is expected to be the market's most lucrative in 2015, with total revenues of $86.5bn, equivalent to 58.9% of the market's overall value.

- Leading US companies operating specifically in the biotechnology sector (such as Gilead Sciences, Amgen, Biogen and Celgene) have grown market capitalizations significantly in recent years, fuelled by speculation that the industry is making real progress towards successful medical advances.

Features

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States

- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts

- Macroeconomic indicators provide insight into general trends within the United States economy

Key Questions Answered

- What was the size of the United States biotechnology market by value in 2015?

- What will be the size of the United States biotechnology market in 2020?

- What factors are affecting the strength of competition in the United States biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the United States's biotechnology market?

Table Of Contents

Biotechnology in the United States
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Amgen, Inc. 20
Baxter International Inc. 23
Biogen, Inc. 26
Merck and Co., Inc. 29
Macroeconomic Indicators 32
Country Data 32
Methodology 34
Industry associations 35
Related MarketLine research 35
Appendix 36
About MarketLine 36

List of Tables
Table 1: United States biotechnology industry value: $ billion, 2011-15(e)
Table 2: United States biotechnology industry category segmentation: $ billion, 2015(e)
Table 3: United States biotechnology industry geography segmentation: $ billion, 2015(e)
Table 4: United States biotechnology industry value forecast: $ billion, 2015-20
Table 5: Amgen, Inc.: key facts
Table 6: Amgen, Inc.: key financials ($)
Table 7: Amgen, Inc.: key financial ratios
Table 8: Baxter International Inc.: key facts
Table 9: Baxter International Inc.: key financials ($)
Table 10: Baxter International Inc.: key financial ratios
Table 11: Biogen, Inc.: key facts
Table 12: Biogen, Inc.: key financials ($)
Table 13: Biogen, Inc.: key financial ratios
Table 14: Merck and Co., Inc.: key facts
Table 15: Merck and Co., Inc.: key financials ($)
Table 16: Merck and Co., Inc.: key financial ratios
Table 17: United States size of population (million), 2011-15
Table 18: United States gdp (constant 2005 prices, $ billion), 2011-15
Table 19: United States gdp (current prices, $ billion), 2011-15
Table 20: United States inflation, 2011-15
Table 21: United States consumer price index (absolute), 2011-15
Table 22: United States exchange rate, 2011-15

List of Figures
Figure 1: United States biotechnology industry value: $ billion, 2011-15(e)
Figure 2: United States biotechnology industry category segmentation: % share, by value, 2015(e)
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2015(e)
Figure 4: United States biotechnology industry value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2015
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2015
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2015
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2015
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2015
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2015
Figure 11: Amgen, Inc.: revenues and profitability
Figure 12: Amgen, Inc.: assets and liabilities
Figure 13: Baxter International Inc.: revenues and profitability
Figure 14: Baxter International Inc.: assets and liabilities
Figure 15: Biogen, Inc.: revenues and profitability
Figure 16: Biogen, Inc.: assets and liabilities
Figure 17: Merck and Co., Inc.: revenues and profitability
Figure 18: Merck and Co., Inc.: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Sample Preparation Market by Product , Consumables ), Application , End Users  - Global Forecast to 2021

Sample Preparation Market by Product , Consumables ), Application , End Users - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves ...

Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, ...

Trends In Gene Therapy

July 2016 $ 5 000

Download Unlimited Documents from Trusted Public Sources

Plant Biotechnology Markets in Mexico

  • September 2016
  • Plant Biotechno...  

    Honey  

    Soybean  

  • Mexico  

    Argentina  

View report >

Genomics Industry in the US

  • September 2016
    49 pages
  • DNA  

    DNA Sequencing  

    Genome Sequenci...  

  • United States  

View report >

Biotech Industry in Europe

  • September 2016
    6 pages
  • Biotech  

  • Europe  

    United States  

    World  

View report >

Related Market Segments :

Biotechnology
Therapy

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.